MOLECULAR REGULATION OF MACROPHAGE CYTOCIDAL ACTIVITY
巨噬细胞杀细胞活性的分子调控
基本信息
- 批准号:3184940
- 负责人:
- 金额:$ 20.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-02-01 至 1989-11-30
- 项目状态:已结题
- 来源:
- 关键词:T lymphocyte affinity chromatography bactericidal immunity cell cell interaction cell mediated cytotoxicity cellular immunity complement complement receptor electron microscopy enzyme inhibitors enzyme mechanism gel electrophoresis human subject hybridomas immunoglobulins ion exchange chromatography laboratory mouse laboratory rabbit laboratory rat leukocyte activation /transformation luminescence macrophage membrane structure migration inhibition factor molecular sieving neoplasm /cancer immunology phagocytes phagocytosis protein biosynthesis radiotracer scintillation counter tissue /cell culture
项目摘要
The ability of macrophages to destroy foreign cells such as bacteria and
neoplastic cells forms the basis of an important mechanism of host
defense. Although macrophage cytocidal activity appears to be a composite
of three reactions involving activation, recognition, and target cell
killing, detailed information of the mechanisms involved in these processes
has remained scarce. This research seeks to elucidate the molecular events
that lead to macrophage activation and to determine the effect of
activation on macrophage recognition reactions and effector cell function.
In the past, we placed particular emphasis on the purification and
characterization of the soluble T-lymphocyte product, denoted macrophage
activating factor (MAF), which is responsible for inducing macrophage
cytocidal activity. On the basis of a variety of biosynthetic,
physiochemical, and immunochemical criteria, we have found that the MAF
activity produced by a murine T-cell hybridoma is totally attributable to
gamma interferon (IFN-gamma). During the past year, we characterized a
specific cell surface receptor for IFN-gamma that regulates macrophage
activation. We also produced monoclonal antibodies to human and murine
IFN-gamma and used these reagents to demonstrate the presence of distinct
functional domains on IFN-gamma that induce different cellular activities.
These antibodies have also been used to show that IFN-gamma is the major
MAF made by normal T lymphocytes. Because of the recent reports that
certain complement proteins can mimic specific lymphokines and influence
activation of mononuclear phagocytes, the role of complement in the
induction of macrophage cytocidal activity also will be examined. The
membrane structures on macrophages that recognize target cells will be
characterized. Phagocyte complement receptors also will be defined. A
detailed analysis will be performed to quantitate the effects of activation
on the function of these two types of cellular recognition structures. The
results of these studies should provide additional insights into the
molecular basis of macrophage function and thus enhance our understanding
of the host defense system. (HF)
巨噬细胞破坏外来细胞如细菌和
肿瘤细胞形成的基础上,一个重要的机制,主机
防御 虽然巨噬细胞的杀细胞活性似乎是一种复合物,
三个反应,包括激活,识别和靶细胞
杀死,这些过程中所涉及的机制的详细信息
一直很稀少这项研究试图阐明分子事件
导致巨噬细胞活化,并确定
激活巨噬细胞识别反应和效应细胞功能。
过去,我们特别强调净化,
可溶性T淋巴细胞产物(表示为巨噬细胞)的表征
活化因子(MAF),其负责诱导巨噬细胞
杀细胞活性。 在多种生物合成的基础上,
根据生理化学和免疫化学标准,我们发现MAF
由鼠T细胞杂交瘤产生的活性完全归因于
γ干扰素(IFN-γ)。 在过去的一年里,我们描绘了一个
调节巨噬细胞的IFN-γ特异性细胞表面受体
activation. 我们还生产了抗人和鼠的单克隆抗体
IFN-γ和使用这些试剂来证明存在不同的
IFN-γ上的功能结构域诱导不同的细胞活性。
这些抗体也被用来表明IFN-γ是主要的
由正常T淋巴细胞产生的MAF。 由于最近有报道称,
某些补体蛋白可以模拟特定的淋巴因子,
单核吞噬细胞的激活,补体在
还将检测巨噬细胞杀细胞活性的诱导。 的
巨噬细胞上识别靶细胞的膜结构将被
表征了 还将定义吞噬细胞补体受体。 一
将进行详细的分析,以量化激活的影响
这两种细胞识别结构的功能。 的
这些研究的结果应该提供更多的见解,
巨噬细胞功能的分子基础,从而提高我们的理解
宿主防御系统 (HF)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT DAVID SCHREIBER其他文献
ROBERT DAVID SCHREIBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT DAVID SCHREIBER', 18)}}的其他基金
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
基于基因组学的个性化癌症免疫治疗的发展
- 批准号:
8887618 - 财政年份:2015
- 资助金额:
$ 20.73万 - 项目类别:
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
基于基因组学的个性化癌症免疫治疗的发展
- 批准号:
9031745 - 财政年份:2015
- 资助金额:
$ 20.73万 - 项目类别:
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path
IFNα/β 和 IFNγ 在先天免疫中的组织特异性作用
- 批准号:
8234935 - 财政年份:2011
- 资助金额:
$ 20.73万 - 项目类别:
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path
IFNα/β 和 IFNγ 在先天免疫中的组织特异性作用
- 批准号:
7672130 - 财政年份:2009
- 资助金额:
$ 20.73万 - 项目类别:
The Molecular and Cellular Basis of Cancer Immunoediting
癌症免疫编辑的分子和细胞基础
- 批准号:
6771282 - 财政年份:2004
- 资助金额:
$ 20.73万 - 项目类别:
The Molecular and Cellular Basis of Cancer Immunoediting
癌症免疫编辑的分子和细胞基础
- 批准号:
7215633 - 财政年份:2004
- 资助金额:
$ 20.73万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 20.73万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 20.73万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 20.73万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 20.73万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 20.73万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 20.73万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 20.73万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 20.73万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 20.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 20.73万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




